Antares Pharma, Inc. (NASDAQ: ATRS) today announced LEO Pharma's launch of OTREXUP to Dermatologists, the first U.S. Food and Drug Administration (FDA) approved subcutaneous (SC) methotrexate (MTX) ...
EWING, N.J., March 28, 2019 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ:ATRS) today announced receipt of orphan drug designation to evaluate the use of subcutaneous methotrexate ("MTX") for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results